-
-
Call more information
660-596-2224 -
ASA Monitor December 2024, Vol. 88, 28–29. Shockwave Medical expands U.S. Peripheral IVL portfolio with enhanced catheter Shockwave Medical, Inc., part of Johnson & Johnson MedTech, announced the full U.S. launch of the Shockwave E8 Peripheral IVL Catheter, following clearance by the FDA. The Shockwave E8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal […]
Read MoreAuthors: Rory V. Mather, MS et al Anesthesiology November 2024. Background With estimated global post-operative mortality rates at 1-4% leading to approximately 3-12 million deaths per year, an urgent need exists for reliable measures of perioperative risk. Existing approaches suffer from poor performance, place a high burden on clinicians to gather data, or do not […]
Read MoreAuthor: Muhammad B. Rafique, MD, FASA ASA Monitor December 2024, Vol. 88, 13–14. He was a brilliant anesthesiologist at the top of his career when, one day, he could not intubate a neonate and was worried. The next day, his family thought he did not look well and took him to the emergency room. A CT […]
Read MoreAuthors: Rita Saynhalath, M.D et al Anesthesiology December 2024, Vol. 141, 1075–1085. Background The Trial Remifentanil DEXmedetomidine (TREX) trial aimed to determine whether, in children less than 2 yr old, low-dose sevoflurane/dexmedetomidine/remifentanil anesthesia is superior to standard-dose sevoflurane anesthesia in terms of global cognitive function at 3 yr of age. The aim of the current secondary […]
Read MoreAuthors: Doug Campbell et al Anesthesiology December 2024, Vol. 141, 1086–1094. Background The Gompertz–Makeham law describes a characteristic pattern of mortality in human populations where the death rate is near constant between ages 18 and 30 yr (Makeham law) and rises exponentially thereafter (Gompertz law). This pattern has not been described in surgical populations, but if […]
Read More